Economic evaluation and budgetary burden of mepolizumab in severe refractory eosinophilic asthma Leticia García-Mochón, Manuel David Gil-Sierra, Emilio Jesús Alegre-del Rey, Catalina Alarcón de la Lastra-Romero, Marina Sánchez-Hidalgo

The relevance of therapeutic positioning in the post-approval evaluation of new drugs Emilio Jesús Alegre-del Rey, Fenix-Caballero, María Dolores Fraga Fuentes, Manuel Jesús Cárdenas Aranzana, Eduardo Lopez-Briz, Francesc Puigventós Latorre, Dominguez-Santana

Assessment of new drugs in a tertiary hospital using a standardized tool J. González-Bueno, E. Chamorro-de-Vega, E.R. Alfaro-Lara, M. Galván-Banqueri, B. Santos-Ramos